Не сдохни! Еда в борьбе за жизнь

^{‹‹29››.} Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med. 2012;366(20):1891–904.

^{‹‹30››.} Liu J, Sui X, Lavie CJ, et al. Association of coffee consumption with all-cause and cardiovascular disease mortality. Mayo Clin Proc. 2013;88(10):1066–74.

^{‹‹31››.} O’Keefe JH, Bhatti SK, Patil HR, DiNicolantonio JJ, Lucan SC, Lavie CJ. Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol. 2013;62(12):1043–51.

^{‹‹32››.} Malerba S, Turati F, Galeone C, et al. A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases. Eur J Epidemiol. 2013; 28(7):527–39.

^{‹‹33››.} Shimamoto T, Yamamichi N, Kodashima S, et al. No association of coffee consumption with gastric ulcer, duodenal ulcer, reflux esophagitis, and non-erosive reflux disease: a crosssectional study of 8,013 healthy subjects in Japan. PLoS ONE. 2013;8(6):e65996.

^{‹‹34››.} Wendl B, Pfeiffer A, Pehl C, Schmidt T, Kaess H. Effect of decaff eination of coffee or tea on gastro-oesophageal reflux. Aliment Pharmacol Ther. 1994;8(3):283–7.

^{‹‹35››.} Lee DR, Lee J, Rota M, et al. Coffee consumption and risk of fractures: a systematic review and dose- response meta-analysis. Bone. 2014;63:20–8.

^{‹‹36››.} Sheng J, Qu X, Zhang X, et al. Coffee, tea, and the risk of hip fracture: a meta-analysis. Osteoporos Int. 2014;25(1):141–50.

^{‹‹37››.} Chen B, Shi HF, Wu SC. Tea consumption didn’t modify the risk of fracture: a dose-response meta- analysis of observational studies. Diagn Pathol. 2014;9:44.

^{‹‹38››.} Nazrun AS, Tzar MN, Mokhtar SA, Mohamed IN. A systematic review of the outcomes of osteoporotic fracture patients after hospital discharge: morbidity, subsequent fractures, and mortality. Ther Clin Risk Manag. 2014;10:937–48.

^{‹‹39››.} Li M, Wang M, Guo W, Wang J, Sun X. The effect of caffeine on intraocular pressure: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2011;249(3):435–42.

^{‹‹40››.} Kang JH, Willett WC, Rosner BA, Hankinson SE, Pasquale LR. Caffeine consumption and the risk of primary open-angle glaucoma: a prospective cohort study. Invest Ophthalmol Vis Sci. 2008;49(5):1924–31.

^{‹‹41››.} Gleason JL, Richter HE, Redden DT, Goode PS, Burgio KL, Markland AD. Caffeine and urinary incontinence in US women. Int Urogynecol J. 2013;24(2):295–302.

^{‹‹42››.} Davis NJ, Vaughan CP, Johnson TM, et al. Caffeine intake and its association with urinary incontinence in United States men: results from National Health and Nutrition Examination Surveys 2005–2006 and 2007–2008. J Urol. 2013;189(6):2170–4.

^{‹‹43››.} Bonilha L, Li LM. Heavy coffee drinking and epilepsy. Seizure. 2004;13(4):284–5.

^{‹‹44››.} Lloret-Linares C, Lafuente-Lafuente C, Chassany O, et al. Does a single cup of coffee at dinner alter the sleep? A controlled cross-over randomised trial in real-life conditions. Nutrition & Dietetics. 2012;69(4):250–5.

^{‹‹45››.} Urgert R, Katan MB. The cholesterol-raising factor from coffee beans. Annu Rev Nutr. 1997; 17:305–24.

^{‹‹46››.} Correa TAF, Rogero MM, Mioto BM, et al. Paper-filtered coffee increases cholesterol and inflammation biomarkers independent of roasting degree: a clinical trial. Nutrition. 2013;29(7–8): 977–81.

^{‹‹47››.} Bhave PD, Hoffmayer K. Caffeine and atrial fibrillation: friends or foes? Heart. 2013; 99(19): 1377–8.

^{‹‹48››.} Patané S, Marte F, La Rosa FC, La Rocca R. Atrial fibrillation associated with chocolate intake abuse and chronic salbutamol inhalation abuse. Int J Cardiol. 2010;145(2):e74–6.